Skip to main content

Table 1 Characteristics of the 1960 cases with ankylosing spondylitis and the 8377 matched population controls

From: Perinatal characteristics, older siblings, and risk of ankylosing spondylitis: a case–control study based on national registers

Demographics

Cases n = 1960

Controls n = 8377

Women (%)

801 (41)

346 (41)

Year of birth median (Q1,Q3)

1979 (1975, 1984)

1979 (1975, 1984)

Age at first AS diagnosis median (Q1, Q3)

27 (22, 30)

NA

Living in same county at time of matching and at birth

1299 (66)

5571 (67)

AS-related inflammatory diseasesa

 Anterior uveitis (%)

337 (17)

22 (0)

 Inflammatory bowel disease (%)

108 (6)

58 (1)

 Psoriasis (%)

89 (5)

49 (1)

 Any of the manifestations above (%)

496 (25)

127 (2)

Rheumatic diagnoses before first AS diagnosisb

 Spondyloarthritis diagnosisc

627 (32)

NA

 Any rheumatic diagnosisd

630 (32)

NA

Pharmacological treatment in 2011e

 TNF-alpha inhibitor (%)

494 (25)

NA

 Methotrexate (%)

161 (8)

NA

 Sulphasalazine (%)

217 (11)

NA

 Any of the treatments above (%)

700 (36)

NA

Years of formal of education in 2008f

 0–9 years

309 (16)

1160 (14)

 10–12 years

880 (45)

3705 (44)

 >12 years

679 (35)

2993 (36)

Disposable income in 2008 £ mean (SD)g

16378 (6797)

16768 (7050)

Maternal diabetes (%)h

12 (0.6)

36 (0.4)

  1. AS ankylosing spondylitis. NA no data available, TNF tumour necrosis factor
  2. aAS-related inflammatory diseases are given as cumulative incidence until 2 years after first AS diagnosis for the cases and their matched controls
  3. bRheumatic diagnoses before first AS diagnosis are based on ICD codes in the National Patient Register
  4. cPsoriatic arthritis, undifferentiated spondyloarthritis, reactive arthritis and spondyloarthritis associated with inflammatory bowel disease
  5. dAny rheumatic disease, see Table S1 in Additional file 1
  6. ePharmacological treatment is based on data in the Prescribed Drug Register for prescriptions during 2011, or in the case of infliximab recoded in the Anti-Rheumatic Therapy in Sweden (ARTIS) register as used during 2011
  7. fNo statistically significant difference in level of formal education based on chi-square test (p = 0.115)
  8. gLimited to those ≥30 years old in 2008 and the 0.5th to the 99.5th percentiles (cases = 953; controls = 3977), no statistically significant difference based on t test (p = 0.125)
  9. hMaternal diabetes prior or during pregnancy, as recorded in the Medical Birth Register. No statistically significant difference based on Fisher’s exact test (p = 0.271)